Potential targets for the new anti-tuberculosis drug of the diarylquinoline group thiozonide

Potential targets for the new anti-tuberculosis drug of the diarylquinoline group thiozonide

Introduction. Diarylquinolines are considered a group of optimal candidates for anti-tuberculosis drugs (ATDs) in the treatment of tuberculosis caused by Mycobacterium tuberculosis exhibiting multidrug resistance.Aim. To perform a computer-aided analysis and evaluation of the potential molecular tar...

Full description

Saved in:

Bibliographic Details
Main Authors:	А. Yu. Savchenko, B. V. Shilov
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2025-06-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	mdr-tuberculosis thiozonide target proteins
Online Access:	https://www.pharmjournal.ru/jour/article/view/2093
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
by: А. Yu. Savchenko, et al.
Published: (2024-01-01)

PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE
by: I. V. Bocharova, et al.
Published: (2014-06-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Short course chemotherapy in children suffering from drug resistant tuberculosis
by: N. I. Klevno, et al.
Published: (2021-03-01)

Safety and Efficacy of Multiple Drug Resistant Tuberculosis Treatment in Patients with Different HIV Statuses
by: S. Yu. Degtyareva, et al.
Published: (2022-02-01)

Deeplex Sequencing of Mycobacterium Tuberculosis Strains Isolated in Kosovo
by: Rrezarta Bajrami, et al.
Published: (2024-12-01)

Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)

Direct drug susceptibility testing of Mycobacterium tuberculosis against primary anti-TB drugs in northern India
by: Anamika Gupta, et al.
Published: (2010-06-01)

HIV infection and multiple drug resistant tuberculosis: the frequency of co-infection and treatment efficacy
by: O. V. Filinyuk, et al.
Published: (2021-03-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

The Role of Risk Factors in the Development of Tuberculosis in Children Exposed to Rifampicin Resistant Tuberculosis
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)

SIDE EFFECTS OF SECOND-LINE ANTITUBERCULOSIS DRUGS IN MULTI-DRUG RESISTANCE (MDR) TUBERCULOSIS PATIENTS
by: Nia Savitri Tamzil, et al.
Published: (2025-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

A Survival Analysis of Successful and Poor Treatment Outcome Among Patients with Drug-Resistant Tuberculosis and the Associated Factors: A Retrospective Cohort Study
by: Putri Bungsu Machmud, et al.
Published: (2021-07-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Tuberculosis multirresistente en adolescente: A propósito de un caso
by: Lorena García-Agudelo
Published: (2025-02-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe
by: Beauty Makamure, et al.
Published: (2017-09-01)

The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis
by: Azhar Iqbal, et al.
Published: (2022-04-01)

QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis
by: A. V. Kukurika
Published: (2024-03-01)

Communicable Episode 20: Tuberculosis today
by: Kathryn Hostettler, et al.
Published: (2025-06-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

MULTI DRUG RESISTANT TUBERCULOSOS IN THE COUNTRIES OF THE OUTER WORLD AND IN THE RUSSIANFEDERATION
by: I. А. Vаsilyevа, et al.
Published: (2017-12-01)

The course of multidrug-resistant pulmonary tuberculosis in HIV-infected people with COVID-19
by: O. M. Raznatovska, et al.
Published: (2022-09-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis
by: V. A. Аksenova, et al.
Published: (2019-07-01)

Preliminary remarks on assembly whole genome sequencing of MDR M. tuberculosis isolated in Vietnam
by: Ngo Viet Quynh Tram, et al.
Published: (2011-12-01)

Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review
by: Salman Daneshi, et al.
Published: (2025-08-01)

Experience of using a combination mucoactive drug during chemotherapy in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2020-08-01)

Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review
by: Michalik, Maciej, et al.
Published: (2025-06-01)

Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation
by: A. I. Gayda, et al.
Published: (2023-01-01)

THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
by: S. Yu. Degtyareva, et al.
Published: (2019-04-01)

Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013
by: Mohammed Yahya Areeshi, et al.
Published: (2014-09-01)

Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola
by: Ngiambudulu M. Francisco, et al.
Published: (2025-03-01)

Clinical characteristic, diagnosis and effectiveness of treatment of tuberculosis in HIV-infected patients in the Saratov region
by: T. I. Morozova, et al.
Published: (2016-04-01)

Features of the simultaneous course of pulmonary aspergillosis and tuberculosis on the background of type 1 diabetes mellitus (clinical case)
by: O. M. Raznatovska, et al.
Published: (2022-10-01)

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis
by: L. V. Panova, et al.
Published: (2021-11-01)

Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance when applied in paucibacillary clinical samples
by: Wenting Jin, et al.
Published: (2025-07-01)